CDC Advisers Weigh Limiting COVID-19 Vaccine Use
Advisers to the Centers for Disease Control and Prevention are considering advising the agency to narrow use of COVID-19 vaccines.A majority of experts in a subgroup of the Advisory Committee on Immunization Practices (ACIP), which advises the CDC on vaccines, have determined that the COVID-19 vaccines should not be universally recommended, according to a presentation Dr. Lakshmi Panagiotakopoulos of the CDC delivered to the panel on April 15.
Seventy-six percent of the advisers in the subgroup studying the matter said they support a non-universal recommendation as of April 3.
That's up from 67 percent in February.
Advisers who were polled said they would be comfortable with any non-universal recommendation, such as only recommending the vaccines for certain age groups.
'I'm very happy that we're seriously considering a risk-based recommendation,' Dr. Jamie Loehr, an ACIP member, said during Tuesday's meeting.
Loehr also said he was concerned that if a risk-based recommendation is implemented, it might send a message that COVID-19 is no longer dangerous, when it's still causing hospitalizations and deaths.
Charlotte Moser, the consumer representative committee member, said she was also supportive of narrowing the recommendation. She said she was thinking that a narrower recommendation, though, should emphasize the importance of vaccinating young children.
Dr. Denise Jamieson, another member, said she did not think a narrower recommendation was wise. She noted that, according to an unpublished CDC analysis of medical claims, some three-quarters of U.S. adults have at least one condition, such as chronic liver disease, that puts them at higher risk of severe illness from COVID-19.
Loehr said that in his own practice, the percentage is much lower.
Advisers said they would be comfortable with any non-universal recommendation, such as only recommending the vaccines for certain age groups.
The CDC currently recommends all Americans aged 6 months and older receive one of the available COVID-19 vaccines, even if they have been vaccinated in the past.
ACIP merely provides advice to the CDC, but the agency typically turns the advice into official recommendations.
A formal ACIP vote on advice to the CDC on the next round of COVID-19 vaccines, or the 2025–2026 vaccines, is not expected to take place until June, according to the CDC.
In a separate presentation delivered during Tuesday's meeting, data from CDC networks showed the effectiveness of the current round of vaccines provides a boost in protection against hospitalization that's under 50 percent.
Ruth Link-Gelles, another CDC employee, who delivered the presentation, concluded that the vaccines 'provided additional protection against COVID-19-associated emergency department and urgent care visits and hospitalizations compared to no 2024-2025 vaccine dose.'
The high level of existing immunity after COVID-19 infection may be affecting the effectiveness results, Link-Gelles said. Prior infection 'contributes protection against future disease, though protection wanes over time,' she said.
About 22 percent of U.S. adults have received one of the 2024–2025 COVID-19 vaccines as of late March 2025, compared to 21 percent who received the vaccines available in 2023 and early 2024 through late March 2024, according to the CDC.
Hospitalizations with COVID-19 are down from the prior year, while hospitalizations with influenza are up from 2023–2024, according to a third presentation. Most of the people who were hospitalized with COVID-19 had not received one of the latest COVID-19 vaccines before being hospitalized.
Also read: Audit: New York's Governor Spent $453M On 247,343 Medical Devices For COVID… State Used Only 3
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Tribune
9 hours ago
- Daily Tribune
WHO Warns of Rising COVID-19 Cases Linked to New Variant NB.1.8.1
The World Health Organization (WHO) has issued a warning over a recent uptick in global COVID-19 infections, linked to the emergence of a newly identified variant, NB.1.8.1, which is currently under investigation by health authorities. Although preliminary assessments indicate that the NB.1.8.1 variant does not present a higher health risk compared to earlier strains, WHO cautioned that the virus's ongoing evolution could spark new waves of infection. The organisation stated that the current surge appears consistent with the virus's seasonal transmission patterns. Despite the increase in cases, WHO noted that the need for hospitalisation and intensive care remains limited, thanks to widespread immunity built through vaccinations and past infections. In its latest assessment, the global health body has classified the overall global risk level as 'high.' It has called on countries to reinforce their public health systems, integrate COVID-19 management into broader seasonal respiratory disease strategies, and counter the spread of misinformation. WHO also urged individuals to continue adhering to basic preventive measures, such as mask-wearing in crowded spaces, frequent handwashing, and staying updated with vaccination schedules, to help curb further spread. The organisation emphasized that vigilance, timely data sharing, and coordinated public health responses remain critical as the world navigates the next chapter of the COVID-19 pandemic.
Daily Tribune
6 days ago
- Daily Tribune
Philippines warns of health emergency as HIV cases soar
AFP | Manila, Philippines Philippine medical authorities on Tuesday warned of a looming "public health emergency" as HIV infections have soared this year, with young males especially hard-hit. On average, 57 new cases a day were tallied in the country of 117 million people over the first three months of 2025, a 50 percent jump from a year earlier, health department data shows. "We now have the highest number of new cases here in the Western Pacific," Health Secretary Ted Herbosa said in a video message released Tuesday. "What is frightening is, our youth make up many of the new cases," he said. "It would be in our interest to (declare) a public health emergency, a national emergency for HIV to mobilise the entire society, the whole of government to help us in this campaign to reduce the number of new HIV cases," Herbosa added. The health department said 95 percent of newly reported cases were male, with 33 percent aged 15-24 and 47 percent aged 25-34. The government did not explain the causes behind the surge, which it said had set back government attempts to hit global targets set by a United Nations campaign to end the AIDS epidemic by 2030. Under Philippine law, the president can declare a health emergency if an epidemic poses a threat to national security. The start of the Covid-19 pandemic in 2020 was the last time that was done. Just 55 percent of those living with HIV in the Philippines have been diagnosed, the health department said, while only 66 percent of those diagnosed are on life-saving antiretroviral therapy. Sexual contact remains the predominant mode of transmission, with the bulk of cases since 2007 attributed to men having sex with men. HIV cases have been on the rise in the Philippines since 2021, with 252,800 people estimated to be living with HIV in the country by the end of this year.
Gulf Insider
6 days ago
- Gulf Insider
Global Tobacco Use Is Steadily Declining
More than 60 years ago, on January 11, 1964, the Surgeon General of the U.S. Public Health Service, Luther L. Terry, M.D., published the first comprehensive report on the effects of smoking on health. A committee was appointed to review and evaluate existing research on the topic in order to 'reach some definitive conclusions on the relationship between smoking and health in general.' And, as Statista's Felix Richter reports, while it may seem absurd from today's point of view that the adverse effects of smoking were ever in doubt, 60 years ago the 'tobacco-health controversy' was exactly that: a controversy. After consulting more than 7,000 articles about the relationship between smoking and disease, the committee did come to a definite conclusion, however, making its report 'Smoking and Health' a landmark study in the fight against smoking. ' On the basis of prolonged study and evaluation of many lines of converging evidence, the Committee makes the following judgement: Cigarette smoking is a health hazard of sufficient importance in the United States to warrant appropriate remedial action. ' (Smoking and Health, 1964) The report found that smoking is a cause of lung cancer and laryngeal cancer in men, a probable cause of lung cancer in women, the most important cause of chronic bronchitis and a contributing factor to cardiovascular diseases, resulting in a higher death rate from coronary artery disease among male cigarette smokers. After its release, it dominated newspaper headlines for days and was later ranked among the top news stories of 1964. And while some tobacco control measures, such as warning labels on cigarette packs, were implemented promptly, cigarette sales in the U.S. continued to rise until the early 1980s, which is when they peaked at more than 630 billion cigarettes per year. Over the past four decades, measures to discourage smoking and protect the public from second-hand smoke have become more and more strict and wide-ranging, resulting in falling tobacco use prevalence in the United States and large parts of the world. Looking at the U.S., the CDC considers the antismoking campaign a 'public health success with few parallels in history', as it achieved its goal despite 'the addictive nature of tobacco and the powerful economic forces promoting its use.' According to WHO estimates, 21.7 percent of all people aged 15 and older used tobacco in 2020, down from 32.7 percent at the turn of the millennium. As the cvhart above nicely illustrates, the tobacco use rate is highest among 45- to 54-year-olds at 27.5 percent, while it's just 13.8 percent among 15- to 24-year-olds and 13.5 percent among those aged 85 and older.
